Introduction: In this study, we aimed to investigate the correlation between Cajal cell density and preoperative and postoperative radiological and scintigraphic parameters in ureteropelvic junction obstruction (UPJO). Methods: The study group consisted of 41 renal units (38 consecutive patients; 13 female and 25 male) surgically treated for UPJO. UPJ specimens from patients were immuno-stained with CD117 (c-kit) antibody for interstitial Cajal cells (ICCs). The relation between Cajal cell density and preoperative and postoperative radiological and scintigraphic parameters was evaluated. Results: The mean age of the patients was 8.52 ± 8.86 (0–35) years. The density of Cajal cells was defined in 2 groups for convenient analysis as 0–5 cells (low) in 19 (46.3%) patients and >5 cells (moderate-high) in 22 (53.6%). There was significant difference between the preoperative and postoperative anteroposterior diameters of the related kidneys in both Cajal groups (p = 0.001-low, p = 0.000-moderate-high) independent of Cajal cell density. Regression in hydronephrosis postoperatively was determined in both Cajal groups (77.8%-low, 64.7%-moderate-high); however, there was no difference between them (p = 0.39). Preoperative T1/2 was significantly longer in the low Cajal group (p = 0.02). Postoperative T1/2 decreased in both low (p = 0.000) and moderate-high (p = 0.001) Cajal groups, but no difference was found between them (p = 0.24). There was significant improvement in the kidney differential function after surgery in the low Cajal density group (p = 0.015) while there was no correlation between the scintigraphic success or improvement and Cajal cell density (p = 0.51). Discussion/Conclusion: ICC deficiency/density could not be shown as a predictive factor for the determination of success rate of pyeloplasty. Despite the lack of any evidence for the degree of deficiency as an indicator for the severity of obstruction and prediction of surgical success, further studies are needed for confirmation.

1.
Carr
MC
,
Casale
P
.
Anomalies and surgery of ureter in children
. In:
Wein
AJ
,
Kavoussi
LR
,
Novick
AC
,
Partin
AW
,
Peters
CA
, editors.
Campbell-Walsh urology
. 10th ed.
Philadelphia
:
Elsevier
;
2016
. p.
3212
34
.
2.
Joyner
BD
,
Mitchell
ME
.
Ureteropelvic junction obstruction
. In:
Grosfeld
J
,
O’Neill
J
,
Coran
A
,
Fonkalsrud
E
, editors.
Pediatric surgery
. 6th ed.
Philadelphia
:
Elsevier
;
2006
. p.
1723
40
.
3.
Krajewski
W
,
Wojciechowska
J
,
Dembowski
J
,
Zdrojowy
R
,
Szydełko
T
.
Hydronephrosis in the course of ureteropelvic junction obstruction: an underestimated problem? Current opinions on the pathogenesis, diagnosis and treatment
.
Adv Clin Exp Med
.
2017
;
26
(
5
):
857
64
. .
4.
Hanna
MK
,
Jeffs
RD
,
Sturgess
JM
,
Barkin
M
.
Ureteral structure and ultrastructure. Part II. Congenital ureteropelvic junction obstruction and primary obstructive megaureter
.
J Urol
.
1976
;
116
(
6
):
725
30
. .
5.
Maizels
M
,
Stephens
FD
.
Valves of the ureter as a cause of primary obstruction of the ureter: anatomic, embryologic and clinical aspects
.
J Urol
.
1980
;
123
(
5
):
742
7
. .
6.
Kiil
F
.
Analysis of myogenic mechanisms in renal autoregulation
.
Acta Physiol Scand
.
2002
;
174
(
4
):
347
55
. .
7.
Krakos
M
,
Andrzejewska
E
.
Abnormalities of ureteral innervation as the base of etiopathogenesis of congenital hydronephrosis in children
.
Przegl Pediatr
.
2004
;
34
(
2
):
94
7
.
8.
Wang
Y
,
Puri
P
,
Hassan
J
,
Miyakita
H
,
Reen
DJ
.
Abnormal innervation and altered nerve growth factor messenger ribonucleic acid expression in ureteropelvic junction obstruction
.
J Urol
.
1995
;
154
(
2
):
679
83
. .
9.
Knerr
I
,
Dittrich
K
,
Miller
J
,
Kummer
W
,
Rösch
W
,
Weidner
W
,
Alteration of neuronal and endothelial nitric oxide synthase and neuropeptide Y in congenital ureteropelvic junction obstruction
.
Urol Res
.
2001
;
29
(
2
):
134
40
. .
10.
Ozel
SK
,
Emir
H
,
Dervisoglu
S
,
Akpolat
N
,
Senel
B
,
Kazez
A
,
The roles of extracellular matrix proteins, apoptosis and c-kit positive cells in the pathogenesis of ureteropelvic junction obstruction
.
J Pediatr Urol
.
2010
;
6
(
2
):
125
9
. .
11.
Solari
V
,
Piotrowska
AP
,
Puri
P
.
Altered expression of interstitial cells of Cajal in congenital ureteropelvic junction obstruction
.
J Urol
.
2003
;
170
(
6
):
2420
2
. .
12.
Koleda
P
,
Apoznanski
W
,
Wozniak
Z
,
Rusiecki
L
,
Szydelko
T
,
Pilecki
W
,
Changes in interstitial cell of Cajal-like cells density in congenital ureteropelvic junction obstruction
.
Int Urol Nephrol
.
2012
;
44
(
1
):
7
12
. .
13.
Cajal
S
.
Sur les ganglions et plexus nerveux de l’intestin
.
CR Soc Biol Paris
.
1893
;
45
:
217
23
.
14.
Piotrowska
AP
,
Solari
V
,
Puri
P
.
Distribution of interstitial cells of Cajal in the internal anal sphincter of patients with internal anal sphincter achalasia and Hirschsprung disease
.
Arch Pathol Lab Med
.
2003
;
127
(
9
):
1192
5
. .
15.
Klemm
MF
,
Exintaris
B
,
Lang
RJ
.
Identification of the cells underlying pacemaker activity in the guinea-pig upper urinary tract
.
J Physiol
.
1999
;
519 Pt 3
(
3
):
867
84
. .
16.
Balikci
Ö
,
Turunç
T
,
Bal
N
,
Celik
H
,
Ozkardes
H
.
Comparison of Cajal-like cells in pelvis and proximal ureter of kidney with and without hydronephrosis
.
Int Braz J Urol
.
2015
;
41
(
6
):
1178
84
. .
17.
Natali
PG
,
Nicotra
MR
,
Sures
I
,
Mottolese
M
,
Botti
C
,
Ullrich
A
.
Breast cancer is associated with loss of the c-kit oncogene product
.
Int J Cancer
.
1992
;
52
(
5
):
713
7
. .
18.
Kacar
A
,
Paker
I
,
Akbiyik
F
,
Arikok
AT
,
Mambet
E
.
CD117 and CD34 staining patterns in childhood benign mammary lesions
.
Turk Patoloji Derg
.
2012
;
28
(
1
):
31
7
. .
19.
Senol
C
,
Onaran
M
,
Gurocak
S
,
Gonul
II
,
Tan
MO
.
Changes in Cajal cell density in ureteropelvic junction obstruction in children
.
J Pediatr Urol
.
2016
;
12
(
2
):
89
5
. .
20.
Issi
O
,
Deliktas
H
,
Gedik
A
,
Ozekinci
S
,
Bircan
MK
,
Sahin
H
.
Does the histopathologic pattern of the ureteropelvic junction affect the outcome of pyeloplasty
.
Urol J
.
2015
;
12
:
2028
31
. .
21.
Inugala
A
,
Reddy
RK
,
Rao
BN
,
Reddy
SP
,
Othuluru
R
,
Kanniyan
L
,
Immunohistochemistry in ureteropelvic junction obstruction and its correlation to postoperative outcome
.
J Indian Assoc Pediatr Surg
.
2017
;
22
(
3
):
129
33
. .
22.
Yang
X
,
Zhang
Y
,
Hu
J
.
The expression of Cajal cells at the obstruction site of congenital pelviureteric junction obstruction and quantitative image analysis
.
J Pediatr Surg
.
2009
;
44
(
12
):
2339
42
. .
23.
Apoznanski
W
,
Koleda
P
,
Wozniak
Z
,
Rusiecki
L
,
Szydelko
T
,
Kalka
D
,
The distribution of interstitial cells of Cajal in congenital ureteropelvic junction obstruction
.
Int Urol Nephrol
.
2013
;
45
(
3
):
607
12
. .
24.
Prisca
RA
,
Loghin
A
,
Gozar
HG
,
Moldovan
C
,
Moso
T
,
Derszi
Z
,
Morphological aspects and distribution of interstitial cells of Cajal in the human upper urinary tract
.
Turk Patoloji Derg
.
2014
;
30
(
2
):
100
4
.
25.
Deliktas
H
,
Issi
O
,
Gedik
A
,
Sahin
H
.
Changes in Collagen Type 3, elastin, fibrosis and Cajal cell in congenital ureteropelvic junction obstruction
.
J Urol Surg
.
2014
;
1
:
11
3
.
26.
Tartaglione
G
,
Townsend
DM
,
Bassi
PF
,
Delgado Bolton
RC
,
Giammarile
F
,
Rubello
D
.
Diuresis renography in equivocal urinary tract obstruction. A historical perspective
.
Biomed Pharmacother
.
2019 Aug
;
116
:
108981
. .
27.
Zhang
Y
,
Ouyang
W
,
Xu
H
,
Luan
Y
,
Yang
J
,
Lu
Y
,
Secondary management for recurrent ureteropelvic junction obstruction after pyeloplasty: a comparison of re-do robot-assisted laparoscopic pyeloplasty and conventional laparoscopic pyeloplasty
.
Urol Int
.
2019
;
103
(
4
):
466
72
. .
28.
Citgez
S
,
Demirdag
C
,
Ozman
O
,
Ozden
SB
,
Derekoylu
E
,
Onal
B
.
Comparison of a modified antegrade and retrograde ureteral double-J stenting techniques during laparoscopic and robotic pyeloplasty
.
Urol Int
.
2020
;
104
(
1–2
):
87
93
. .
29.
Cheng
S
,
Li
X
,
Yang
K
,
Xiong
S
,
Li
Z
,
Zhu
H
,
Modified Laparoscopic and robotic flap pyeloplasty for recurrent ureteropelvic junction obstruction with a long proximal ureteral stricture: the “Wishbone” anastomosis and the “Ureteral Plate” technique
.
Urol Int
.
2021
:
1
8
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.